<DOC>
	<DOCNO>NCT01001143</DOCNO>
	<brief_summary>The main objective determine safety tolerability combination decitabine bexarotene four cycle therapy .</brief_summary>
	<brief_title>Intravenous ( IV ) Decitabine Oral Bexarotene Acute Myelogenous Leukemia ( AML )</brief_title>
	<detailed_description>The investigator seek study combination decitabine bexarotene . These two agent show efficacy decrease leukemic blast count restore normal hematopoiesis via different mechanism action non-overlapping side-effect profile . By combine agent , investigator hope improve overall response rate . The investigator hope improve platelet neutrophil count even great number patient , thus treat two important source morbidity mortality patient population .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Decitabine</mesh_term>
	<mesh_term>Azacitidine</mesh_term>
	<mesh_term>Bexarotene</mesh_term>
	<criteria>AML bone marrow blast ≥ 20 % . Relapsed disease 1 line prior salvage chemotherapy FABAML , Diagnosis AML age ≥ 60 candidate cytotoxic chemotherapy FABAML except FABM3 . Performance status ≤ 2 . Age ≥ 18 year . Peripheral white blood cell count ( WBC ) &gt; 10,000/microliter . Total bilirubin &gt; 1.5 x normal . AST/ALT &gt; 2.5 x normal . Serum creatinine &gt; 2 x normal . Fasting serum triglyceride &gt; 1,000 mg/dL . Active poorly control graft v host disease ( GVHD ) . Pregnant nursing . Known CNS leukemia . History positive HIV serology . History positive Hepatitis C serology . Uncontrolled intercurrent illness include , limited , ongoing active infection , congestive heart failure NYHA class 3 4 , unstable angina pectoris , cardiac arrhythmia , psychiatric illness/social situation would limit compliance study requirement . Chemotherapy within 21 day enrollment . Radiation therapy within 14 day enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2014</verification_date>
</DOC>